[CIS PIDD] ALPS versus CVID patient with progressing lymphoproliferative syndrome
Dr. Carsten Speckmann
carsten.speckmann at uniklinik-freiburg.de
Mon Jun 11 08:11:45 EDT 2012
To me the disease sounds "too aggressive" for ALPS.
I would not overinterpret the DNT count. Biomarker prolife? (e.g.
Vitamin B12 elevated?)
Did you rule out XIAP (e.g. by flow) and CGD (by DHR) in this boy with
Crohn`s disease?
He has B lymphopenia. Besides CD8 Lymphopenia any other T cell
abnormalities / signs for CID?
low naives, impaired proliferation, g/d TCR expansion? - RAG?
Radiosensitivity? (see Rohr et al. 2010 "Chronic inflammatory bowel
disease as key manifestation of atypical ARTEMIS deficiency")
CD25 expression?
Bodo Grimbacher very recently described LRBA deficiency - a PID with
childhood onset hypogamma (and in some with severe enteropathy)
- if none of the other DD seem likely (WB screening is available).
Carsten
Am 11.06.12 13:46, schrieb Sanchez Ramon.Silvia:
>
> Dear colleagues,
>
> we are taking care of a 15-yo boy followed by Digestive Dept. since
> 2007 for Crohn disease (biopsy not conclusive), and axillary
> polyadenopathies. Past medical history of atopic dermatitis and
> chronic migraines, negative for recurrent infections. He was referred
> in 2011 to us due to splenomegaly, multiple laterocervical
> adenopathies and hypogammaglobulinemia (IgG: 343 mg/dL; IgA 30 mg/dL
> and IgM: 28.6 mg/dL). He was clinically well.
> At that time he showed lymphopenia B of 3%, with low switched-memory B
> cells of 3%; very low CD8+ T lymphocytes of 3%. Low baseline Ab titers
> to TT and pneumococcal Ag (he was on steroids 56 mg po/d for IBD). His
> WBC have been stable around 2000-2500/uL with moderate neutropenia of
> 600-700/uL; Lymphos 3,300/μL. The remaining series are normal (Hb:
> 12.8 g/dL Hematocrit 37.1 %; platelets: 135 10E3/μL ).
> Normal expression of ZAP70 on T lymphocytes; normal HLA class I and
> II; IL-2, IL-7 and IFNγ receptors expression. Noted to have 6% double
> negative T cells (CD3+CD4-CD8-) alpha-beta; Gamma-delta cells 3%. No
> other features of ALPS. He was given IVIg replacement therapy, with
> suspicion of CVID (TACI mutation was negative) versus ALPS.
>
>
> Other investigations
> Coeliac disease screening: negative. Other autoantibodies (ANA, ENA,
> ANCA): negative. Normal complement. Normal TSH, T4L. Direct Coombs
> negative.
> Normal serum biochemistries. Ferritin, vit.B12, folate: all normal.
> Extensive viral/bacterial investigations, including: Serologies to
> CMV, EBV, toxoplasma, HB, HC, HIV1-2, bartonella, parvovirus negative.
> Repeated negative PCR for CMV and VEB.
>
> In the last months the latero-cervical enlarged lymph nodes with
> approx 5 cm diameter, and splenomegaly (of 15 cm). Several cervical
> lymph nodes biopsies have shown lymphoid hyperplasia suggesting
> unspecific lymphoproliferative disorder, with high proliferative rate
> (Ki67), without necrosis areas or granulomas, without evidence of
> malignity and EBV (IHC and ISH) negative. There is a predominance of
> CD4 T cells, disperse B cells of probable follicular origin
> (CD20/CD79a/Bcl6+) and TFh (PD1+) cells. No Reed-Sternberg cells or
> non-haematopoietic neoplastic cells. PCR study: IgH gene: (FR1/JH):
> polyclonal (FR2/JH): polyclonal (FR3/JH): polyclonal. TCR-gamma (VJ-A)
> gene: polyclonal (VJ-B): polyclonal.
>
> Bone marrow biopsy: normocellular BM parenchyma (3/5), without
> madurative changes. Multifocal mature lymphohistiocytic aggregates and
> interstitial lymphocytosis of predominantly CD4+ T cells (IHC). No
> blast cell aggregates, parasites, fungi, viral cytopathic inclusions,
> siderosis, mielofibrosis (except on the lymphohistiocytic nodules), or
> bone alterations were observed. No non-haematopoietic neoplastic
> infiltrates were observed.
> Cervical ultrasound: bilateral intraparotideal, yugulodigastric and
> laterocervical adenopathies, more evident at the right side.
> Thoracoabdominal CT: Thoracic and abdominopelvic adenopathies, some
> of them of 4.5 and 3.2 cm diameter, bilateral lung nodules and
> hepatosplenomegaly.
> PET-scan: multiple bilateral laterocervical, thoracic, abdominopelvic
> lymphadenopathies, and multiple bone and bilateral lung nodules
> compatible with the diagnosis of lymphoproliferative syndrome.
>
> Given the suspected ALP syndrome with multiple lymphadenopathies,
> therapy with Sirolimus (3.7 mg/24 h po after initial charge dosis) was
> started in Jan 2012. He showed a significant improvement of
> adenopathies and recovery of neutropenia, with no secondary effects.
> He started with lumbalgia in January 2012. MRI disclosed a vertebral
> L4 body lesion with extension to intervertebral foramina L3-L4 and
> L4-L5. Biopsies showed non-caseating granulomas. PCR panfungal:
> negative. Parasites and mycobacteria: negative. PCR Universal 16S rARN
> negative. PCR Bartonella sp. neg. PCR Aspergillus sp. neg. PCR
> Panfungal negative. PCR CMV <100 copies/mL. Hemocultures,
> coprocultures x3, nasopharyngeal cultures all negatives. Negative
> quantiferon. At the Oncohematology Unit the patient was then given one
> cycle of chemotherapy, with COP (ciclophosphamide 400 mg/m2 1 dosis,
> vincristine 1.5mg/m2 and prednisone 60 mg/m2 X7 days.
> Despite of this, a new MRI shows paravertebral and epidural mass with
> soft-tissue extension and increased signal in T1 and turbo stir. New
> sacral and lumbar bone lesions. The radiological image suggests
> progression of the lymphoproliferative disorder versus metastatic lesions.
>
> He’s on prophylactic Bactrim, IVIg and sirolimus, and tapering doses
> of prednisone. Currently ongoing: study of caspase 8 and 10, and
> Fas/FasL mutations.
>
> We are concerned about the clinical course of this young patient and
> on the best management for him, since we still have no definitive
> diagnosis.
>
> 1. What other treatment possibilities? Thoughts on chemotherapy?
> 2. What other tests or diagnoses would you consider?
>
> Thanks so much in advance for your help.
>
> Best regards,
>
> Dra. Dolores Gurbindo, Section of Immunopediatrics
> Dra. Silvia Sánchez-Ramón, Unit of Clinical Immunology
>
> Silvia SÁNCHEZ-RAMÓN, MD, PhD
> Unidad de Inmunología Clínica
> Departamento de Inmunología
> Hospital General Universitario Gregorio Marañón
> Calle Doctor Esquerdo, 46
> E- 28007 - Madrid, Spain
> Tel: +34 914265181
> FAX: +34 915868018
> E-mail: ssanchez.hgugm at salud.madrid.org
>
>
> ------------------------------------------------------------------------
> "Este mensaje, o sus anexos, pueden contener información confidencial,
> en especial datos de carácter personal, y se dirigen exclusivamente al
> destinatario del mismo que está obligado al secreto profesional
> respecto de la información y los datos contenidos en el mensaje. Si
> usted lo ha recibido por error, por favor, comuníquenoslo por este
> medio y proceda a destruirlo o borrarlo, y en todo caso absténgase de
> utilizar, reproducir, alterar, archivar o comunicar a terceros el
> presente mensaje y/o ficheros anexos, pudiendo incurrir, en caso de
> llevar a cabo tales acciones, en responsabilidades legales. En
> cualquier caso, la reproducción o comunicación a terceros de la
> información contenida en el presente mensaje o en sus anexos debe
> estar previamente autorizada por el emisor. El emisor no garantiza la
> integridad, rapidez o seguridad del presente correo, ni se
> responsabiliza de posibles perjuicios derivados de la captura,
> incorporaciones de virus o cualesquiera otras manipulaciones
> efectuadas por terceros."
--
Dr. med. Carsten Speckmann
Facharzt
Zentrum fuer Kinderheilkunde und Jugendmedizin
Centrum fuer Chronische Immundefizienz - CCI
Universitaet Freiburg
Mathildenstr. 1
79106 Freiburg
Germany
phone: +49 (0)761-270 43010
mail: carsten.speckmann at uniklinik-freiburg.de
web: www.cci.uniklinik-freiburg.de
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://seven.pairlist.net/mailman/private/pagid/attachments/20120611/ca125794/attachment.html>
More information about the PAGID
mailing list